Valuation: Terumo Corporation

Market Cap 3,215B 19.82B 17.29B 15.96B 14.65B 27.83B 1,910B 28.31B 189B 74.49B 933B 74.48B 72.83B P/E 2027 *
19.3x
P/E 2028 * 17.3x
Enterprise Value 3,291B 20.29B 17.7B 16.33B 14.99B 28.48B 1,955B 28.98B 193B 76.24B 955B 76.23B 74.54B EV / Sales 2027 *
2.66x
EV / Sales 2028 * 2.46x
Free-Float
97.07%
Yield 2027 *
1.64%
Yield 2028 * 1.83%
1 day-2.40%
1 week-6.22%
Current month-2.44%
1 month-0.91%
3 months+1.11%
6 months-4.32%
Current year-3.99%
1 week 2,168.5
Extreme 2168.5
2,266.5
1 month 2,146.5
Extreme 2146.5
2,364.5
Current year 1,900
Extreme 1900
2,463
1 year 1,900
Extreme 1900
2,818
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
-2.40%-6.22%-10.88%+0.09% 20.34B
+1.06%-6.86%-32.39%-17.29% 155B
+1.48%-4.01%-10.32%-8.19% 102B
-1.89%-2.60%-0.16%+54.93% 58.81B
-0.94%-1.23%+39.41%+54.08% 52.82B
+2.81%-0.91%-12.54%-40.29% 41.51B
+2.02%-8.30% - - 32.69B
-1.88%-1.14%-14.77%-47.04% 28.6B
+0.38%+0.82%+59.92%-6.78% 25.27B
+1.31%-1.82%-6.35%-7.69% 20.34B
Average +0.10%-3.31%+1.32%-2.02% 53.68B
Weighted average by Cap. +0.24%-4.30%-7.49%-1.52%

Financials

2027 *2028 *
Net sales 1,236B 7.62B 6.65B 6.14B 5.63B 10.7B 735B 10.89B 72.56B 28.65B 359B 28.65B 28.01B 1,315B 8.11B 7.07B 6.53B 5.99B 11.38B 782B 11.58B 77.17B 30.47B 382B 30.47B 29.79B
Net income 166B 1.02B 890M 822M 754M 1.43B 98.36B 1.46B 9.71B 3.84B 48.05B 3.83B 3.75B 185B 1.14B 996M 919M 844M 1.6B 110B 1.63B 10.87B 4.29B 53.76B 4.29B 4.2B
Net Debt 75.69B 467M 407M 376M 345M 655M 44.98B 667M 4.44B 1.75B 21.97B 1.75B 1.71B 14.29B 88.11M 76.87M 70.94M 65.11M 124M 8.49B 126M 839M 331M 4.15B 331M 324M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
15/07/26 ¥2,179.50 -2.40% 3,917,600
14/07/26 ¥2,233.00 +0.88% 3,221,300
13/07/26 ¥2,213.50 +1.12% 3,004,900
10/07/26 ¥2,189.00 -1.73% 4,601,900
09/07/26 ¥2,227.50 -2.15% 3,400,200
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,179.50JPY
Average target price
2,961.54JPY
Spread / Average Target
+35.88%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock